Search research articles
Contact Us
Filters
Showing results (621-630 of 1,099) with videos related to
Page
of 110
Sort By:
The Ocular Surface
|
August 3, 2022
Topical glaucoma medications - Clinical implications for the ocular surface
Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil, et al.
The Ocular Surface
|
October 27, 2019
Investigation of factors associated with ABCB5-positive limbal stem cell isolation yields from human donors
Yuzuru Sasamoto, Naoko Sasamoto, Johnathan Tran, et al.
The Ocular Surface
|
May 24, 2021
The relationship between alcohol consumption and dry eye
Morten Schjerven Magno, Tishelle Daniel, Mathias Kaurstad Morthen, et al.
The Ocular Surface
|
June 8, 2021
Relationships between activated dendritic cells and dry eye symptoms and signs
Harry Levine, Jodi Hwang, Harrison Dermer, et al.
The Ocular Surface
|
June 26, 2022
Lacrimal gland regeneration: The unmet challenges and promise for dry eye therapy
Induvahi Veernala, Jilu Jaffet, Jasmin Fried, et al.
The Ocular Surface
|
December 8, 2022
Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study
Adam Wylegala, Wathanee Sripawadkul, Mike Zein, et al.
The Ocular Surface
|
December 31, 2022
A systematic review on the effects of ROCK inhibitors on proliferation and/or differentiation in human somatic stem cells: A hypothesis that ROCK inhibitors support corneal endothelial healing via acting on the limbal stem cell niche
Lloyd R Kopecny, Brendon W H Lee, Minas T Coroneo
The Ocular Surface
|
January 7, 2021
Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease
Baikai Ma, Yifan Zhou, Rongjun Liu, et al.
The Ocular Surface
|
June 25, 2021
Medication use and dry eye symptoms: A large, hypothesis-free, population-based study in the Netherlands
Laura E Wolpert, Harold Snieder, Nomdo M Jansonius, et al.
The Ocular Surface
|
June 18, 2021
Corneal nerve changes following treatment with neurotoxic anticancer drugs
Jeremy Chung Bo Chiang, David Goldstein, Susanna B Park, et al.
Page
of 110
Search research articles
Search
Showing results (621-630 of 1,099) with videos related to
Sort By:
Page
of 110
The Ocular Surface
|
August 3, 2022
Topical glaucoma medications - Clinical implications for the ocular surface
Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil, et al.
The Ocular Surface
|
October 27, 2019
Investigation of factors associated with ABCB5-positive limbal stem cell isolation yields from human donors
Yuzuru Sasamoto, Naoko Sasamoto, Johnathan Tran, et al.
The Ocular Surface
|
May 24, 2021
The relationship between alcohol consumption and dry eye
Morten Schjerven Magno, Tishelle Daniel, Mathias Kaurstad Morthen, et al.
The Ocular Surface
|
June 8, 2021
Relationships between activated dendritic cells and dry eye symptoms and signs
Harry Levine, Jodi Hwang, Harrison Dermer, et al.
The Ocular Surface
|
June 26, 2022
Lacrimal gland regeneration: The unmet challenges and promise for dry eye therapy
Induvahi Veernala, Jilu Jaffet, Jasmin Fried, et al.
The Ocular Surface
|
December 8, 2022
Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study
Adam Wylegala, Wathanee Sripawadkul, Mike Zein, et al.
The Ocular Surface
|
December 31, 2022
A systematic review on the effects of ROCK inhibitors on proliferation and/or differentiation in human somatic stem cells: A hypothesis that ROCK inhibitors support corneal endothelial healing via acting on the limbal stem cell niche
Lloyd R Kopecny, Brendon W H Lee, Minas T Coroneo
The Ocular Surface
|
January 7, 2021
Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease
Baikai Ma, Yifan Zhou, Rongjun Liu, et al.
The Ocular Surface
|
June 25, 2021
Medication use and dry eye symptoms: A large, hypothesis-free, population-based study in the Netherlands
Laura E Wolpert, Harold Snieder, Nomdo M Jansonius, et al.
The Ocular Surface
|
June 18, 2021
Corneal nerve changes following treatment with neurotoxic anticancer drugs
Jeremy Chung Bo Chiang, David Goldstein, Susanna B Park, et al.
Page
of 110